Antenatal screening for HIV in Australia: Time to revise policies?

Medical Journal of Australia

Volumn 171, Issue 4, 1999, Pages 201-203

  Ziegler, John B ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CESAREAN SECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT FEEDING; PRENATAL SCREENING; SHORT SURVEY; VERTICAL TRANSMISSION;

EID: 0033575740     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1999.tb123598.x     Document Type: Short Survey

References (25)

1. National Centre for HIV Epidemiology and Clinical Research. HIV/AIDS and related diseases in Australia. Annual surveillance report 1998. Sydney: NCHECR, 1998.
2. Dunn DT, Newell ML, Ades AE, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-588.
3. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1 : the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175: 661-667.
4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 173-1180.
5. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339: 1409-1414.
6. Shatter N, Chuchuwong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353: 773-780.
7. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999; 353: 781-785.
8. Dabis F, Msellati P, Meda N, et al. 6 month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353: 786-792.
9. Saba J, The results of the PETRA intervention trial to prevent perinatal transmission in sub-Saharan Africa [abstract]. Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections. 1999 31 Jan-4 Feb; Chicago, III. Alexandria, Va: Foundation for Retrovirology and Human Health. .
10. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999; 340: 977-987.
11. The European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 1035-1039.
12. Ziegler JB, Cooper DA, Johnson RO, et al. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; I: 896-898.
13. Palasanthiran P, Ziegler JB, Stewart GJ, et al. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 1993; 167: 441-444.
14. Riley LE, Greene MF. Elective cesarean delivery to reduce the transmission of HIV. N Engl J Med 1999; 340: 1032-1033.
15. National Centre for HIV Epidemiology and Clinical Research. HIV/AIDS and related diseases in Australia. Annual Surveillance Report 1999. Sydney: NCHECR, 1999.
16. McDonald AM, Cruickshank M, Ziegler JB, et al. Perinatal exposure to HIV in Australia, 1982-1994. Med J Aust 1997; 166: 77-80.
17. New South Wales Health Department. HIV antibody testing for pregnant women. Circular No. 97/27, issued 5 Mar 1997.
18. Australian National Council on AIDS and Related Diseases, Intergovernmental Committee on AIDS and Related Diseases. HIV testing policy. Canberra: Commonwealth Department of Health and Aged Care, 1998: 18.
19. Nicoll A, McGarrigle C, Brady AR, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ 1998; 316: 253-258.
20. Boxall E. Screening of pregnant women for hepatitis B. Vaccine 1998; 16 Suppl: S30-S33.
21. Lindgren S, Bohlin AB, Forsgren M, et al. Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ 1993; 307: 1447-1451.
22. Simpson WM, Johnstone FD, Boyd FM, et al. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ 1998; 316: 262-267.
23. Elford J, MacDonald MA, Gabb RG, et al. Antenatal HIV antibody testing in Australia. Med J Aust 1995; 163: 183-185.
24. McLaws ML, Brown ARD, Cunningham PH, et al. Prevalence of maternal HIV infection based on anomymous testing of neonates, Sydney 1989. Med J Aust 1990; 153: 383-386.
25. Ziegler JB, Cruickshank M, Langdon P, et al. Is antenatal screening for HIV costeffective? [abstract]. Abstracts of the 3rd National Conference on Medical and Scientific Aspects of HIV/AIDS. 1991 Nov 22; Wollongong, NSW. Sydney: ASHM, 1991.